1. ellaOne®: a second-generation emergency contraceptive?;Mansour, D.;J Fam Plann Reprod Health Care,2009
2. The effects of immediate pre-ovulatory administration of 30 mg ulipristal acetate on follicular rupture. Abstract presented at the 8th Congress of the European Society of Gynecology;Croxatto, H.B.; Brache, V.; Cochon, L.; Jesam, C.; Salvatierra, A.M.; Levy, D.,2009
3. Pituitary–ovarian function following the standard levonorgestrel emergency contraceptive dose or a single 0.75-mg dose given on the days preceding ovulation;Croxatto, H.B.; Brache, V.; Pavez, M.; Cochon, L.; Forcelledo, M.L.; Alvarez, F.;Contraception,2004
4. Progesterone receptor modulator for emergency contraception: a randomized controlled trial;Creinin, M.D.; Schlaff, W.; Archer, D.F.; Wan, L.; Frezieres, R.; Thomas, M.;Obstet Gynecol,2006
5. Ulipristal acetate compared to levonorgestrel for emergency contraception within five days of unprotected intercourse: a randomised controlled trial. Abstract presented at the 8th Congress of the European Society of Gynecology;Cameron, S.; Glasier, A.; Fine, P.; Mathe, H.; Gainer, E.,2009